LBA53A phase II, randomised, open-label study of...

Annals of Oncology 2017 / 09 Vol. 28; Iss. suppl_5

LBA53A phase II, randomised, open-label study of gemcitabine/carboplatin first-line chemotherapy in combination with or without the antisense oligonucleotide apatorsen (OGX-427) in advanced squamous cell lung cancers

Schmid, P., Blackhall, F., Muthukumar, D., Lester, J., Khan, S., Adams, J., Illsley, M., Macgregor, C., Owadally, W., Sarker, S-J., Smith, L., Prendergast, A., Ackerman, C., Mousa, K., Farah, L. Lim
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
28
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdx440.056
Date:
September, 2017
File:
PDF, 85 KB
2017
Conversion to is in progress
Conversion to is failed